linoleic acid 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
3323 60-33-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • linoleic acid
  • alpha-Linoleic acid
  • linolic acid
A doubly unsaturated fatty acid, occurring widely in plant glycosides. It is an essential fatty acid in mammalian nutrition and is used in the biosynthesis of prostaglandins and cell membranes. (From Stedman, 26th ed)
  • Molecular weight: 280.45
  • Formula: C18H32O2
  • CLOGP: 7.30
  • LIPINSKI: 1
  • HAC: 2
  • HDO: 1
  • TPSA: 37.30
  • ALOGS: -6.26
  • ROTB: 14

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Hepatotoxicity 64.97 46.73 16 167 37025 63451814

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Hepatotoxicity 57.62 50.99 16 244 51336 79692792
Regurgitation 53.25 50.99 9 251 2778 79741350

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
CHEBI has role CHEBI:76924 plant metabolites
CHEBI has role CHEBI:83038 Daphnia galeata metabolites
CHEBI has role CHEBI:84735 algal metabolites

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 4.76 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Prostaglandin G/H synthase 1 Enzyme IC50 4.89 CHEMBL
Aromatase Enzyme IC50 4.32 CHEMBL
Aldo-keto reductase family 1 member C3 Enzyme IC50 6.16 CHEMBL
Peroxisome proliferator-activated receptor alpha Nuclear hormone receptor Kd 8.32 CHEMBL
Peroxisome proliferator-activated receptor gamma Nuclear hormone receptor IC50 5.21 CHEMBL
Fatty acid-binding protein, adipocyte Cytosolic other IC50 6 CHEMBL
Fatty acid-binding protein, heart Cytosolic other Kd 9.70 CHEMBL
Peroxisome proliferator-activated receptor delta Nuclear hormone receptor IC50 5 CHEMBL
Free fatty acid receptor 1 GPCR AGONIST EC50 5.70 IUPHAR
Potassium voltage-gated channel subfamily B member 1 Ion channel ACTIVATOR EC50 5.60 IUPHAR
Tissue factor Membrane receptor IC50 4.39 CHEMBL
Free fatty acid receptor 4 GPCR AGONIST EC50 5.89 IUPHAR
Nuclear receptor subfamily 4 group A member 2 Nuclear other Kd 4.30 CHEMBL
Adenosine receptor A1 GPCR IC50 4.19 CHEMBL
Seed linoleate 13S-lipoxygenase-1 Enzyme IC50 6 CHEMBL
Prostaglandin G/H synthase 2 Enzyme IC50 4.03 CHEMBL

External reference:

IDSource
4020238 VUID
N0000148142 NUI
4020238 VANDF
C0023749 UMLSCUI
CHEBI:17351 CHEBI
EIC PDB_CHEM_ID
CHEMBL267476 ChEMBL_ID
DB14104 DRUGBANK_ID
D019787 MESH_DESCRIPTOR_UI
5280450 PUBCHEM_CID
1052 IUPHAR_LIGAND_ID
9KJL21T0QJ UNII
6400 RXNORM
005003 NDDF
012326 NDDF

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
PrimaCare HUMAN PRESCRIPTION DRUG LABEL 14 75854-322 PILL 50 mg oral unapproved drug other 11 sections
Dr.Different VITAACNAL TX Capsule Serum HUMAN OTC DRUG LABEL 2 81710-110 LIQUID 0.76 g TOPICAL unapproved drug other 8 sections
Anubis Barcelona Vital Line HUMAN OTC DRUG LABEL 23 83021-064 CREAM 0.16 g TOPICAL OTC monograph final 5 sections
AnubisMed HUMAN OTC DRUG LABEL 28 83021-551 CREAM 0.50 g TOPICAL OTC monograph final 7 sections
Anubis Barcelona Protective Line HUMAN OTC DRUG LABEL 27 83021-686 CREAM 0.50 g TOPICAL OTC monograph final 9 sections
Anubis Barcelona Protective Line HUMAN OTC DRUG LABEL 27 83021-686 CREAM 0.50 g TOPICAL OTC monograph final 9 sections